Foundation for a smoke free world: Biomarkers of nicotine product use (Scoping Proposal)

At the end of the funding period, the Foundation expects delivery of a prototype diagnostic (biomarker or panel of biomarkers) that can reliably discriminate between the nicotine-delivery product groups. This will include proof-of-concept bench testing, in-field/clinic validation of the diagnostic, and a plan for scale-up in developed and low- and middle-income economies.

Funding:

Phase One: Scoping Proposal $100K

Phase Two up to $3M per project for 2 years

(Non- profit)

https://www.smokefreeworld.org/our-areas-focus/request-proposal-biomarkers-nicotine-product-use